Bicalutamide Tablets India Supplier | Genliva Pharma Exporter Prostate Cancer Drug

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Genliva Wellness LLP is a trusted Bicalutamide Tablets Manufacturer in India producing advanced anti-androgen formulations for prostate cancer treatment and hormonal oncology care.

Bicalutamide Tablets are widely prescribed for the management of advanced prostate cancer and hormone-dependent malignancies. The formulation contains Bicalutamide, a non-steroidal anti-androgen that blocks androgen receptors and helps inhibit the stimulatory effects of testosterone on prostate cancer cells.

The company also supplies these formulations as an Oncology Care Medicine Supplier and Anti Androgen Tablets Exporter for cancer care centers, hospital oncology departments, institutional procurement programs, and regulated international pharmaceutical markets.

Bicalutamide Tablets are formulated for anti-androgen and prostate cancer therapy.

Contains Bicalutamide as active ingredient
Non-steroidal anti-androgen formulation
Androgen receptor blocking activity
Oral oncology tablet dosage form
Designed for hormonal cancer therapy
Suitable for prostate cancer management

This formulation is prescribed in oncology and hormonal therapy management.

Treatment of advanced prostate cancer
Management of metastatic prostate cancer
Used in hormone-dependent cancer therapy
Administered in anti-androgen treatment protocols
Supports androgen suppression strategies
Utilized in long-term oncology care

Bicalutamide Tablets deliver targeted anti-androgen support for prostate cancer treatment.

Helps block androgen receptor stimulation
Supports hormonal cancer management
Useful in advanced prostate cancer therapy
Convenient oral tablet administration
Suitable for long-term treatment protocols